傲農生物(603363.SH):擬將傲芯生物51%股權轉讓給漳州鴻楓
格隆匯9月14日丨傲農生物(603363.SH)公佈,公司於2023年9月13日與漳州鴻楓農業科技有限公司(稱“漳州鴻楓”)簽署了《福建傲芯生物科技集團有限公司股權合作意向協議》,公司擬將持有的福建傲芯生物科技集團有限公司(稱“傲芯生物”)51%股權轉讓給漳州鴻楓。根據評估機構評估意見,目標公司股東全部權益價值為14.67億元。本次交易如果順利實施,預計公司通過本次交易可獲得資金7億多元,預計可產生投資收益超過10億元,有助於優化公司資產負債結構,改善公司現金流,降低資產負債率。
漳州鴻楓目前股東為萬文峯持股70%、福建芯育生物科技有限公司(簡稱“福建芯育”)持股10%、漳州萊福德農業投資有限公司(簡稱“漳州萊福德”)持股10%、漳州市聚芯農業投資有限公司(簡稱“漳州聚芯”)持股10%。萬文峯系公司長期合作方,系傲芯生物管理層,目前擔任傲芯生物總經理。福建芯育、漳州萊福德、漳州聚芯系擬以傲芯生物員工為主體的持股平台,後續將吸收傲芯生物及其下屬控股企業的核心骨幹員工進入持股平台。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.